All-cause mortality | ||||||
---|---|---|---|---|---|---|
Peri-menopausal | Post-menopausal | |||||
45 ≤ Age < 55 | Age ≥ 55 | |||||
 | Death (%)(n = 15) | Adj HR†(95% CI) ‡ | PAR (%) (95% CI)‡ | Death (%)(n = 63) | Adj HR†(95% CI) ‡ | PAR (%) (95% CI)‡ |
MetS | 4 (26.7) | 1.70 (0.33-4.86) | 13.4 (1.6-35.3) | 35 (55.6) | 1.89 (1.05-3.59)* | 19.5 (4.1-32.9) |
High WC | 8 (53.3) | 2.33 (0.66-10.90) | 26.5 (3.2-51.6) | 46 (73.0) | 1.48 (0.79-3.44) | 16.6 (1.5-39.4) |
AH | 6 (40.0) | 2.48 (0.64-9.38) | 25.0 (3.0-47.1) | 42 (66.7) | 2.14 (1.21-4.27)* | 33.2 (11.6-50.6) |
DM | 0 (0.0) | N/A§ | N/A§ | 22 (34.9) | 1.99 (1.02-3.64)* | 11.8 (2.18-20.0) |
High TG | 3 (20.0) | 1.64 (0-4.70) | 9.1 (0.7-26.7) | 17 (27.0) | 1.20 (0.64-2.31) | 3.2 (0.3-13.5) |
Low HDL-C | 2 (13.3) | 0.61 (0-2.21) | N/A§ | 21 (33.3) | 1.12 (0.58-1.97) | 2.9 (0.4-16.2) |
CVD-related mortality | ||||||
Peri-menopausal | Post-menopausal | |||||
45 ≤ Age < 55 | Age ≥ 55 | |||||
 | Death (%) (n = 3) | Adj HR†(95% CI) ‡ | PAR (%) (95% CI)‡ | Death (%) (n = 28) | Adj HR†(95% CI) ‡ | PAR (%) (95% CI)‡ |
MetS | 2 (66.7) | 6.21 (N/A§) | 41.9 (4.3-86.8) | 18 (64.3) | 2.95 (1.39-8.71)* | 42.5 (19.4-64.7) |
High WC | 3 (100) | N/A§ | N/A§ | 22 (78.6) | 3.38 (1.52-15.1)* | 47.8 (21.2-71.3) |
AH | 2 (66.7) | 6.44 (N/A§) | 52.8 (4.0-100) | 18 (64.3) | 1.93 (0.88-5.50) | 36.0 (6.37-68.1) |
DM | 0 | N/A§ | N/A§ | 11 (39.3) | 2.78 (1.16-7.31)* | 22.8 (4.99-38.6) |
High TG | 2 (66.7) | 11.5 (N/A§) | 45.6 (11.2-85.7) | 9 (32.1) | 1.65 (0.51-4.88) | 11.4 (1.4-30.4) |
Low HDL-C | 1 (33.3) | 3.96 (N/A§) | 28.0 (2.99-75.0) | 15 (53.6) | 2.51 (1.06-6.11)* | 24.5 (5.22-42.3) |